Meggan M. Walsh
Known title: DirectorCIK: 0002027788
Meggan M. Walsh's purchase track record
Meggan M. Walsh has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/22/2025 | PHIN | $60K | +32.3% | +21.6% | +11.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PHIN | ▲ Buy | Grant | 10 | $0 | 9/18/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 8 | $0 | 6/23/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 2,140 | $0 | 5/22/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 3/20/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 15 | $0 | 9/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 6/16/2025 | View on chart |
| PHIN | ▲ Buy | Open Market | 1,400 | $60K | 5/22/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 3,299 | $0 | 5/21/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 17 | $0 | 3/14/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 13 | $0 | 12/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 15 | $0 | 9/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 2,485 | $0 | 8/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.